NATO chief concerned over Russia's actions in SyriaWorld October 26, 18:28
Armed OSCE mission may be deployed to Donbass after security zones set up — diplomatRussian Politics & Diplomacy October 26, 18:18
Diplomat: Humanitarian organizations fail to ensure evacuation from AleppoRussian Politics & Diplomacy October 26, 18:15
First footage of post-Soviet Joint Air Defense System drillsMilitary & Defense October 26, 18:15
Putin says Kerch Bridge will allow to carry up 13 mln vehicles per yearBusiness & Economy October 26, 17:59
Another German delegation gearing up for possible visit to Crimea in JanuaryWorld October 26, 17:42
Russia expects opening of major oilfields in West Siberia next yearBusiness & Economy October 26, 17:37
Russian defense minister suggests joint engineering troops’ drills with IndiaMilitary & Defense October 26, 17:33
Russia calls on media to focus on Mosul’s children killed during US-led coalition strikesRussian Politics & Diplomacy October 26, 17:14
MOSCOW, November 21. /ITAR-TASS/. The Russian Health Ministry has expressed concern over a big number of pharmacies in Russia, which provokes price dumping policies and lowers pharmacy quality standards, Health Minister Veronika Skvortsova told the Presidium of the Russian government on Thursday.
The Russian pharmacy market has a huge number of economic entities running the production and distribution sectors. A total of 550 organizations and a thousand foreign pharmacies have licenses for medicine production and deliveries, Skvortsova said with reference to the Single License Register of the Russian Ministry of Industry and Trade.
In Russia, there is one pharmacy per every 1,450 people, in the United States - one pharmacy per every 4,500 people and in Germany - one pharmacy per 3,900 people, she said. There is a surplus number of pharmacies in Russia; the quality of pharmacy services is worsening; the share of pharmacies capable to produce medicines or which have the necessary conditions for the storage of medicines and narcotic-containing stuff has been declining, Skvortsova said.
Creation of vertically integrated structures and large pharmacy networks hinders the development of a competitive environment, provokes price dumping and creates problems for producers of medicines, Skvortsova said.